Seattle Genetics, Inc. (Nasdaq: SGEN) today announced that its collaborator, Takeda Pharmaceutical Company Limited (Takeda), has received approval of ADCETRIS (brentuximab vedotin) from the Japanese Ministry of Health, Labour and Welfare ...
Takeda Pharmaceutical Company Limited ("Takeda") and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc., today announced that the United States (U.S.) Food & Drug Administration (FDA) has extended the Prescription Drug User ...
Tags: Takeda Pharmaceutical Company Limited, Prescription Drug User Fee Act
Pfizer's rheumatoid arthritis treatment, tofacitinib, has obtained approval in several additional countries globally, including Switzerland, Argentina, Kuwait, UAE and Russia for patients with inadequate response to current therapies. The ...
Takeda Pharmaceutical Company, AMAG Pharmaceuticals' European commercial partner, has submitted a type-II variation to the European Medicines Agency (EMA) for label expansion of Rienso (ferumoxytol). The approval will allow the use of ...
Tags: Takeda, EMA Approval
Takeda Pharmaceutical Company said it will start using bio-polyethylene bottles (“Bio-PE bottles”) as the primary packaging container for the hypertension treatment product, Azilva. Made from plastic derived from ...
Tags: Takeda Pharma, Packaging, Bottles
Takeda Pharmaceutical Company has submitted marketing authorisation application (MAA) seeking approval from the European Medicines Agency (EMA) for its investigational, gut-selective humanized monoclonal antibody for the treatment of adults ...
Tags: Takeda, IBD Disease Drug, MAA, EMA
Takeda Pharmaceutical Company has announced the approval of Helicobacter pylori Gastritis as an additional indication to eradicate Helicobacter pylori using triple therapy with proton pump inhibitor by Japan's Ministry of Health, Labour and ...
Tags: Helicobacter pylori Gastritis, Helicobacter pylori eradication
The Osaka Prefectural Government has issued an order for corrective action concerning the manufacturing and marketing of ALINAMIN-F5 injection to Takeda Pharmaceutical Company. A violation of the Pharmaceutical Affairs Act coupled with ...
Tags: Osaka Prefectural Government, Takeda Pharmaceutical Company
Sanford-Burnham Medical Research Institute and Florida Hospital have revamped obesity research partnership with Takeda Pharmaceutical Company for the discovery of novel anti-obesity therapeutics. The extended collaboration leverages new ...
Tags: Sanford-Burnham, Florida Hospital, obesity research, Takeda
Takeda Pharmaceutical Company and Millennium: The Takeda Oncology Company have won European conditional marketing authorization for Adcetris (brentuximab vedotin). Adcetris is indicated for use in adult patients with relapsed or ...
Tags: adcetris, antibody-drug conjugate, Brentuximab vedotin, sALCL
Takeda Pharmaceutical Company and NPS Pharmaceuticals have announced positive opinion from the Committee for Medicinal Products for Human Use (CHMP) for Teduglutide (Revestive) for patients with short bowel syndrome (SBS). Teduglutide, ...
Tags: short bowel syndrome, teduglutide, glucagon-like peptide 2
Takeda Pharmaceutical Company and H. Lundbeck have submitted a new drug application (NDA) to the FDA for vortioxetine (Lu AA21004), an investigational drug for the treatment of major depressive disorder (MDD). Vortioxetine is under ...
Tags: Takeda Pharmaceutical Company, major depressive disorder, MDD
Takeda America Holdings, a wholly owned subsidiary of Takeda Pharmaceutical Company, has acquired URL Pharma for an upfront payment of $800m. Takeda will begin the integration of URL Pharma and will right away assume responsibility for ...
Affymax has earned $50m development milestone payment from Takeda Pharmaceutical Company for the US approval of OMONTYS (peginesatide) injection. The company has also received another $5m milestone payment, which was triggered by the ...
The EMA Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of AMAG Pharmaceuticals' ferumoxytol, an iron deficiency anemia (IDA) therapy. The intravenous (IV) iron therapy, indicated for the treatment of ...
Tags: AMAG Pharmaceuticals, iron deficiency anemia(IDA)therapy